How is malign glaucoma to return a responsibility

Update Date: Source: Network

summary

Malignant glaucoma is also known as ciliary ring block angle closure glaucoma. It is characterized by elevated intraocular pressure and anterior movement of lens iris septum, which makes all anterior chambers shallow or even disappear. Typical cases often occur several hours, days or even months after operation.

How is malign glaucoma to return a responsibility

For malignant glaucoma, we should take emergency measures as soon as possible to reduce the pressure on the back of the eyeball and break the ciliary ring block. At the same time, we must take drugs including hypertonic agents, carbonic anhydrase inhibitors and cycloplegic agents, supplemented with corticosteroids,

To reduce inflammation and ciliary edema. The commonly used drugs are: 1% atropine and 10% Novolin solution or 0.5% tropicamide. The eyedrops are alternately applied several times a day. The dilated pupil can make the ciliary body move backward. If the anterior chamber is formed and the intraocular pressure is normal after drug treatment, the drugs can be subtracted one by one. First stop the high dose, then stop the carbonic anhydrase inhibitor, and the cycloplegic agent should last for a long time, If the drug treatment is invalid after 4-5 days, the surgical treatment can be changed.

The surgical treatment includes vitreous puncture, drainage and anterior chamber inflation. If it is not effective, lens extraction or vitrectomy should be adopted. If the intraocular pressure is still high after the release of ciliary ring block, acetazolamide and timolol can be taken orally.

matters needing attention

This disease only occurs in angle closure glaucoma, especially in the operation, although the intraocular pressure is low, but the angle is still occluded, often double eye disease, that is, one eye after malignant glaucoma, the other eye because of mydriasis agent, that is, the possibility of malignant glaucoma. If preventive peripheral iridectomy is performed in one eye, it can not prevent the occurrence of malignant glaucoma, but also induce it.